Acceptability of self-collected human papillomavirus specimens as a primary screen for cervical cancer

Journal of Obstetrics and Gynaecology

Volumn 32, Issue 1, 2012, Pages 87-91

  Quincy, B L ^a   Turbow, D J ^b   Dabinett, L N ^c  

^a ELON UNIVERSITY   (United States)

^b Trident University International   (United States)

^c Women's Center of Winchester   (United States)

Author keywords

Acceptability; Cervical cancer; Human papillomavirus; Self collection

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EXAMINATION; COLPOSCOPY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; FEMALE; HUMAN; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; NICARAGUA; PERCEPTION; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF COLLECTED HUMAN PAPILLOMAVIRUS TEST; UTERINE CERVIX CANCER; UTERUS BIOPSY; VIRUS EXAMINATION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; SELF CARE; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84455161130     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2011.625456     Document Type: Article

References (26)

1. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC. 2005. Acceptability of self-collection of specimens for HPV DNA Testing in an urban population. Journal of Women ' s Health 14:721-730.
2. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D et al. 2003. Management of women who test positive for high-risk types of human papillomavirus: Th e HART study. Lancet 362:1871-1876. (Pubitemid 37518501)
3. DeAlba I, Anton-Culver H, Hubbell A, Ziogas A., Hess JR, Bracho A et al. 2008. Self-sampling for human papillomavirus in a community setting: Feasibility in Hispanic women. Cancer Epidemiology Biomarkers and Prevention 17:2163-2168.
4. Dzuba IG, Diaz EY, Allen B, Leonard YF, Ponce ECL, Shah KV et al. 2002. Th e acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. Journal of Women ' s Health and Gender-Based Medicine 11:265-274.
5. Flores Y, Bishai D, Lazcano E, Shah K, Lorincz A, Hernandez M et al. 2003. Improving cervical cancer screening in Mexico: Results from the Morelos HPV study. Salud Publica Mexicana 45:S388-S398. (Pubitemid 38035109)
6. Flores Y, Shah K, Lazcano EC, Hernandez M, Bishai D, Ferris D et al. 2002. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: Th e Morelos HPV Study. Salud Publica Mexicana 44:335-344. (Pubitemid 34951473)
7. Goldie SJ, Gaffi kin L, Goldhaber-Fiebert AB, Gordillo-Tobar A, Levin C, Mahe C et al. 2005. Cost-eff ectiveness of cervical-cancer screening in fi ve developing countries. New England Journal of Medicine 353:2158-2168. (Pubitemid 41653107)
8. Kahn JA, Bernstein DI, Rosenthal SL, Huang B, Kollar LM, Colyer JL et al. 2005. Acceptability of human papillomavirus self testing in female adolescents. Sexually Transmitted Infections 81:408-414. (Pubitemid 41494356)
9. Khanna N, Mishra SI, Tian G, Tan MT, Arnold S, Lee C et al. 2007. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. International Journal of Gynecologic Cancer 17:615-622. (Pubitemid 46744000)
10. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. 2000. Human papillomavirus DNA testing for cervical cancer screening in lowresource settings. Journal of the National Cancer Institute 92:818-825.
11. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM et al. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities. Journal of the American Medical Association 288:1749-1757.
12. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A et al. 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal Medicine 357:1579-1588. (Pubitemid 47598400)
13. Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jeronimo J et al. 2008. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 26S:L37-L48.
14. Ogilvie G, Krajden M, Maginley J, Isaac-Renton J, Hislop G, Elwood-Martin R et al. 2007. Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women. Canadian Medical Association Journal 177:480-483. (Pubitemid 47359771)
15. Pereira SM, Castelo A, Makabe S, Utagawa ML, DiLoreto C, Maeda MY et al. 2005. Screening for cervical cancer in high-risk populations: DNA Pap test or Hybrid Capture II test alone? International Journal Gynecologic Pathology 25:38-41. (Pubitemid 44638333)
16. Ronco G, Giorgi-Rossi P, Carozzi F, Palma PD, Del Mistro A, De Marco L et al. 2006. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: Results at recruitment for a randomised controlled trial. Lancet Oncology 7:547-555. (Pubitemid 43923665)
17. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A et al. 2008. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. Journal of the National Cancer Institute 100:492-501.
18. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A et al. 2010. Effi cacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomized controlled trial. Lancet Oncology 11:249-257.
19. Salmeron J, Lazcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, Leyva A et al. 2003. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 14:505-512. (Pubitemid 36999965)
20. Sankaranarayanan R, Nene B, Shastri SS, Jayant K, Muwonge R, Budukh AM et al. 2009. HPV screening for cervical cancer in rural India. New England Journal of Medicine 360:1385-1394.
21. Schiff man M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S et al. 2000. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. Journal of the American Medical Association 283:87-93. (Pubitemid 30038388)
22. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P et al. 2000. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Canadian Medical Association Journal 163:513-518.
23. Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J et al. 2007. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. Journal of Medical Screening 14:34-42. (Pubitemid 46440364)
24. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Nicaragua. 2009. Summary Report 2009. Geneva, Switzerland: World Health Organization Document Production Services. Available at: www. who.int/hpvcentre (Accessed: 27 October 2009).
25. WHO. 2007. Cervical cancer, human papillomavirus (HPV), and HPV vaccines: Key points for policy-makers and health professionals. Geneva, Switzerland: World Health Organization Document Production Services. Available at: www.who.int/reproductive-health/ publications/cervical-cancer-keypoints/cerv- cancer-hpv-keypts.pdf (Accessed 2 May 2009).
26. Wikstrom I, Stenvall H, Wilander E. 2007. Attitudes to self-sampling of vaginal smear for human papillomavirus analysis among women not attending organized cytological screening. Acta Obstetrica Gynecologica 86:720-725. (Pubitemid 46801783)